The Treatment of Tuberculosis in HIV-Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1997

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

Ethambutol hydrochloride

DRUG

Isoniazid

DRUG

Pyrazinamide

DRUG

Pyridoxine hydrochloride

DRUG

Levofloxacin

DRUG

Rifampin

Trial Locations (12)

10016

NY Univ. HIV/AIDS CRS, New York

10021

Cornell University A2201, New York

10029

Beth Israel Med. Ctr. (Mt. Sinai), New York

14215

SUNY - Buffalo, Erie County Medical Ctr, Buffalo

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

20059

Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.

21287

Johns Hopkins Adult AIDS CRS, Baltimore

33136

Univ. of Miami AIDS CRS, Miami

45267

Univ. of Cincinnati CRS, Cincinnati

60612

Cook County Hosp. CORE Ctr., Chicago

90033

USC CRS, Los Angeles

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001033 - The Treatment of Tuberculosis in HIV-Infected Patients | Biotech Hunter | Biotech Hunter